# PIMAVANSERIN
> **ANDA214925** · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2024-01-16
## Drug
- **FDA Application Number:** ANDA214925
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PIMAVANSERIN
- **Generic name:** PIMAVANSERIN
- **Active ingredients:** PIMAVANSERIN TARTRATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** MSN
- **Manufacturer:** Novadoz Pharmaceuticals LLC
- **First approval:** 2024-01-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214925)
---
*AI Analytics · CC0 1.0*